← Open Payments lookup

DIANA MATA: Open Payments

NPI 1821354242 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$206 in 9 payments from 6 companies in 2025. Trend: 2023 $40 · 2024 $109 · 2025 $206

Food & beverage: $206
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.2$46
Otsuka America Pharmaceutical, Inc.2$40
Vanda Pharmaceuticals Inc.1$37
Alkermes, Inc.2$33
Neurocrine BioSciences, Inc.1$27
ABBVIE INC.1$24

Products named: UZEDY, FANAPT, INGREZZA, VRAYLAR, ABILIFY MAINTENA, LYBALVI, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across MD — which companies pay providers there.